My WebLink
|
Help
|
About
|
Sign Out
Home
Browse
Search
Correspondence #41
Clerk
>
Agenda Packets / Staff Reports
>
City Council (2004 - Present)
>
2022
>
12/20/2022 Special & Regular
>
Correspondence #41
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
12/22/2022 9:49:20 AM
Creation date
12/20/2022 10:02:48 AM
Metadata
Fields
Template:
City Clerk
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
117
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
where: <br />DoseA,R = dose by inhalation (mg/kg/day), per age group <br />CPF = cancer potency factor, chemical -specific (mg/kg/day)-1 <br />ASF = age sensitivity factor, per age group <br />FAH = fraction of time at home, per age group (for residential receptors only) <br />ED = exposure duration (years) <br />AT = averaging time period over which exposure duration is averaged (always 70 years) <br />Consistent with the 363-day construction schedule, the annualized average concentration for <br />construction was used for the entire third trimester of pregnancy (0.25 years), and the first 0.74 years of <br />the infantile stage of life (0 — 2 years). The annualized average concentration for operation was used for <br />the remainder of the 30-year exposure period, which makes up the latter 1.26 years of the infantile <br />stage of life, as well as the entire child (2 —16) and adult (16 — 30 years) stages of life. The results of our <br />calculations are shown in the table below. <br />The Maximally Exposed Individual at an Existing Residential Receptor <br />Concentration <br />Age Group <br />Emissions Source <br />Duration (years) <br />Cancer Risk <br />(ug/m3) <br />3rd Trimester <br />Construction <br />0.25 <br />0.1049 <br />1.43E-06 <br />t."Onstrrvua:bon <br />0,74 <br />0,104 9 <br />1,281..05 <br />Infant (0 - 2) <br />Total <br />2 <br />7.16E-05 <br />Child (2 - 16) <br />Operation <br />14 <br />0.2849 <br />1.03E-04 <br />Adult (16 - 30) <br />Operation <br />14 <br />0.2849 <br />1.15E-05 <br />Lifetime <br />30 <br />1.88E-04 <br />As demonstrated in the table above, the excess cancer risks for the 3rd trimester of pregnancy, infants, <br />children, and adults at the MEIR located approximately 200 meters away, over the course of Project <br />construction and operation, are approximately 1.43, 71.6, 103, and 11.5 in one million, respectively. The <br />excess cancer risk over the course of a residential lifetime (30 years) is approximately 188 in one million. <br />The infant, child, adult, and lifetime cancer risks exceed the SCAQMD threshold of 10 in one million, thus <br />resulting in a potentially significant impact not previously addressed or identified by the EA. <br />Our analysis represents a screening -level HRA, which is known to be conservative and tends to err on <br />the side of health protection. The purpose of the screening -level HRA is to demonstrate the potential <br />link between Project -generated emissions and adverse health risk impacts. According to the U.S. EPA: <br />Rl <br />
The URL can be used to link to this page
Your browser does not support the video tag.